Roanoke, Virginia, 24153, United States
NCT Number: NCT00808340
Comparison of Three Soft Bifocal Contact Lenses
The primary purpose of the study is to compare the performance of three soft bifocal contact lenses in terms of the vision provided by the lenses.
Looking for future studies?
Notify MeKey information
Conditions
Age range
35 year–70 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- The subject must between 35 and 70 years of age.
- The subject must respond positively to at least one symptom on the "Presbyopic Symptoms Questionnaire" or be already wearing presbyopic contact lens correction ( e.g. reading spectacles over contact lenses, multifocal or monovision contact lenses etc.).
- The subject's spherical equivalent distance refraction must be in the range of -1.00 to -6.00 in each eye.
- Refractive cylinder must be less than or equal to -0.75 D in each eye.
- The subject must have an add power of +0.75D to +2.50D in each eye.
- The subject must have best corrected visual acuity of 20/20-3 or better in each eye.
- The subject's must have at least 20/30-distance vision with the study contact lenses.
- The subject must agree that they are comfortable with their vision prior to being dispensed the study lenses.
- The subject must be an adapted soft contact lens wearer in both eyes.
- The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
- The subject must read and sign the STATEMENT OF INFORMED CONSENT and be provided a copy of the form.
Exclusion criteria
- Ocular or systemic allergies or disease that may interfere with contact lens wear.
- Systemic disease, autoimmune disease or use of medication, which may interfere with contact lens wear.
- Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining or any other abnormality of the cornea, which may contraindicate contact lens wear.
- Clinically significant (grade 3 or 4) tarsal abnormalities that might interfere with contact lens wear.
- Any ocular infection.
- Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
- Pregnancy or lactation
- Any infectious disease (e.g., hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g., HIV).
- History of diabetes. History of binocular vision abnormality or strabismus.
Treatment and study plan
balafilcon A
Devicemultifocal contact lens
senofilcon A production
Devicemultifocal contact lens
senofilcon A test
Devicemultifocal contact lens
Primary outcomes
-
Distance Bright Illumination Binocular Visual Performance Reported as Visual Acuity
Time frame: 5 minutes after insertion
Tested with both eyes together in bright lighting, reading charts distant to the subject. This outcome is measured in logMAR units.LogMAR stands for the logarithm of the minimum angle of resolution. Ideal is 0.0 and represents 20/20 Snellen acuity. logMAR values > 0.00 indicate vision poorer than the ideal and values <0.00 indicate vision greater than the ideal.
-
Near Bright Illumination Binocular Visual Performance Reported as Visual Acuity
Time frame: 5 minutes after insertion
Tested with both eyes together in bright lighting reading charts near to the subject. This outcome is measured in logMAR units.LogMAR stands for the logarithm of the minimum angle of resolution. Ideal is 0.0 and represents 20/20 Snellen acuity. logMAR values > 0.00 indicate vision poorer than the ideal and values <0.00 indicate vision greater than the ideal.
-
Type of Corneal Staining
Time frame: after 1 week of lens wear, for each lens type
Investigator rated type of corneal staining as either 0=none, 1=micropunctate, 2=macropunctate, 3=coalesced, or 4=patch(> or = to mm).
-
Overall Subjective Vision
Time frame: after 1 week of lens wear, for each lens type
Subject rated the overall quality of vision with the study contact lenses. 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.
Sponsors and collaborators
Lead sponsor
Johnson & Johnson Vision Care, Inc.
Industry
Registry information
Important dates
- Study start
- 2008
- Primary completion
- 2008
- Study completion
- 2008
- First posted
- Dec 15, 2008
- Registry last updated
- Jun 19, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Evaluate the Efficacy and Safety of CTO0307 in Adults With Presbyopia
NCT07723716
Eye Diseases, Presbyopia
Seoul, South Korea
View Trial DetailsSafety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia
NCT05646719
Eye Diseases, Presbyopia
Phoenix, Arizona, United States
View Trial DetailsPilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
NCT07076160
Eye Diseases, Presbyopia
Jacksonville, Florida, United States
View Trial DetailsVisionApp - Refraction and Presbyopia
NCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial Details